27-28 September, 2018

Boston, USA

The Novel Analgesic Drug Discovery Summit will help bridge the gap between discovering novel analgesic targets and developing successful novel and next generation therapeutics to treat pain by showcasing the most exciting and maturing (from a translational and clinical viability perspective) targets and classes of next generation pain drug currently under investigation.

With drug developers venturing into developing safe and effective alternative pain to tackle the unmet medical need for patients suffering from pain, you’ll have the opportunity to demonstrate real world case studies of your expertise to prove ROI amongst the industry, and advance the positioning of your solutions and services to drive the field of next generation pain discovery and development towards success.

Why Partner with us?

Benefit from Market Intelligence

Hear how and where drug developers are looking for external expertise to robustly translate their pre-clinical research into clinical development with success

Position Yourself as an Industry Thought Leader

With the US in the midst of an opioid crisis, it has never been more critical to innovate and accelerate the discovery and development of novel therapeutics to treat pain. Demonstrate your expertise through podium presentations, moderating panel discussions or interactive roundtables

Raise Brand Awareness

Benefit from pre and post conference exposure to our key decision maker community and increase market share through unique branding formats

Meet and Network with Industry Pioneers

With a room full of drug developers looking to see how they can effectively optimize discovery of novel analgesic targets and successfully translate them into clinic meet prospective clients during speed networking breaks, 1-2-1 meetings and more informal networking receptions

Generate Commercial Collaborations

Make sure your hottest prospects are in the room and part of the discussion, by having a wish-list of your choice contacted in advance of the event

 

For further information please don’t hesitate to send us an email.